Becton, dickinson and company:1106636 [17-019909]
Ended Awarded Last action
- Contract number
- HHSN26100001
- Awardee
-
Becton, Dickinson And Company UEI MM5ZHL8SRFY5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $17,906
Award facts
- Contract value 100% obligated
- $17,905.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 811219 Other Electronic and Precision Equipment Repair and Maintenance
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Jose, CA 95131, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $17,906 |
About this award
Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, was awarded a $17,905.92 firm fixed price Blanket Purchase Agreement (BPA) call by the National Cancer Institute (NCI) on March 30, 2017, with an ultimate completion date of March 31, 2018. This contract award, designated as a child contract under a larger vehicle, represents performance to be completed at the contractor's San Jose, California facility. The award utilized full and open competition with no small business set-aside designation. BD Biosciences, a global medical technology company specializing in flow cytometry, cell imaging, and genomics technologies, has established itself as a primary federal supplier of sophisticated scientific instruments and reagents to multiple National Institutes of Health components and other federal healthcare and research institutions.
This contract call falls within NCI's broader procurement strategy for advanced biomedical research instrumentation and supplies. BD's extensive federal contract portfolio demonstrates the company's competitive positioning in providing flow cytometry systems, analytical instruments, reagents, and associated technical support services to government research facilities. The relatively modest ceiling value suggests this particular call likely involved consumable supplies, reagents, or targeted equipment components required for ongoing cancer research initiatives at NCI-supported facilities. BD's established relationships with NCI and other federal agencies, supported by multiple indefinite delivery vehicles with the Department of Veterans Affairs and NIH Clinical Center, reflect the company's sustained role in supporting government biomedical research and healthcare operations.
Quick answers
Who was awarded contract HHSN26100001?
HHSN26100001 was awarded to Becton, Dickinson And Company by National Cancer Institute (National Institutes of Health) on March 30, 2017.
How much is contract HHSN26100001 worth?
The government has obligated $17,906 on HHSN26100001.
Is contract HHSN26100001 an order under another contract?
Yes. HHSN26100001 is a BPA call under HHSN263201600133B, a blanket purchase agreement.
Was contract HHSN26100001 competed?
The extent of competition for HHSN26100001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award